Myotonic Dystrophy Team Members

Erick P. Greene, MD, FAAN

Director, Neuromuscular and Myotonic Dystrophy Clinics
Neurologist
Dr. Greene's clinical interests include a wide range of neuromuscular disorders, such as muscular dystrophy, myasthenia gravis, neuropathy, amyotrophic lateral sclerosis (ALS), inflammatory myopathy, and mitochondrial and metabolic myopathy.
713.363.7310

Ashley E. L. Anderson, MD, MPH

Neurologist
Dr. Anderson has special interest in neuromuscular disorders, such as amyotrophic lateral sclerosis (ALS), amyloid neuropathy, myasthenia gravis, and other related disorders.
713.363.7310

Sheetal Shroff, MD

Neurologist
Dr. Shroff focuses on clinical trials of investigational new drugs for the treatment of myasthenia gravis, muscular dystrophy, amyotrophic lateral sclerosis (ALS) and chronic inflammatory demyelinating polyneuropathy (CIDP).
713.363.7310 

Jason R. Thonhoff, MD, PhD

Neurologist, physician-scientist
Dr. Thonhoff's research focuses on the role of regulatory T cells (Tregs) in amyotrophic lateral sclerosis (ALS). The loss of Treg function is associated with the acceleration of disease progression in ALS.
713.363.7310

Nilesh Mathuria, MD

Cardiologist
Dr. Mathuria’s clinical interests include atrial fibrillation, biventricular pacing, Watchman, defibrillator implantation, supraventricular tachycardia and ventricular tachycardia. 832.522.8355

Research & Clinic Coordinator
Rachel Applegate, BS, CCRC
713.441.9120

Clinical Research
Patricia Mendoza, RN, CCRC
713.441.5855

Social Work Services
Rebecca Axline, LCSW-S, APHSW-C 
713.441.3812
Julie Schwarz, LCSW
713.441.9164

Physical Therapist
Wendy E. Schell, PT, DPT, MS, CSRS
713.441.2675

Occupational Therapist
Pam Glazener, OTR, ATP
713.441.2675

Speech Pathologists
Carolyn Martinez, MA, CCC-SLP
713.441.5916
Felicia Carter, MA, CCC-SLP
713.363.9357

Dietitian
Margaret Farnsworth RD, LD
Dena Furman, RD, LD
713.441.2147

Muscular Dystrophy Association
Monica Meriwether
832.900.5343


Share: